Memantine and somnolence Patient Reports February 12, 2012

Memantine Side Effects Report #5692881-9
Memantine side effect was reported by a Consumer or non-health professional from FRANCE on Mar 18, 2008. Female patient, 94 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: diet refusal, disturbance in attention, gait disturbance, incontinence, somnolence. Memantine dosage: 5 MG QD PO. During the same period patient was treated with LEVOTHYROXINE, INDAPAMIDE, DILTIAZEM HYDROCHLORIDE. Patient recovered.

Memantine Side Effects Report #5150743-X
Memantine side effect was reported by a Health Professional from JAPAN on Oct 31, 2006. Male patient, 92 years of age, weighting 128.1 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: cerebral infarction, depressed level of consciousness, fall , gait disturbance, restlessness, somnolence. Memantine dosage: unknown. During the same period patient was treated with PITAVASTATIN CALCIUM, NICERGOLINE, DENOPAMINE, DIGESTIVE ENZYME PREPARATIONS, FAMOTIDINE, CITICOLINE, CYANOCOBALAMIN, THIAMINE DISULFIDE NITRATE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #6023564-3
Memantine side effect was reported by a Pharmacist from GERMANY on Dec 11, 2008. Female patient, 89 years of age, weighting 108.0 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: aggression, agitation, somnolence. Memantine dosage: 20 MG (10 MG, 2 IN 1 D), ORAL. During the same period patient was treated with ATHYMIL, IMOVANE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5302412-0
Memantine side effect was reported by a Health Professional from GERMANY on Apr 02, 2007. Male patient, 88 years of age, weighting 147.5 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: arthritis , blood pressure systolic increased, bronchopneumonia, c-reactive protein increased, cough, decreased activity, pyrexia, somnolence. Memantine dosage: 20 MG QD PO. During the same period patient was treated with AMLODIPINE BESYLATE, TEPRENONE, ASPIRIN, URSODIOL, TERBINAFINE, BETAMETHASONE DIPROPIONATE. Patient was hospitalized. Patient recovered.


Memantine Side Effects Report #5104106-3
Memantine side effect was reported by a Health Professional from JAPAN on Aug 31, 2006. Male patient, 88 years of age, weighting 147.5 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: arthritis , blood pressure systolic increased, bronchopneumonia, c-reactive protein increased, cough, decreased activity, somnolence. Memantine dosage: 20 MG QD PO. During the same period patient was treated with AMLODIPINE BESYLATE, TEPRENONE, ASPIRIN, URSODEOXYCHOLIC ACID, TERBINAFINE, BETAMETHASONE DIPROPIONATE, TIAPRIDE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5302412-0
Memantine side effect was reported by a Health Professional from GERMANY on Apr 02, 2007. Male patient, 88 years of age, weighting 147.5 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: arthritis , blood pressure systolic increased, bronchopneumonia, c-reactive protein increased, cough, decreased activity, pyrexia, somnolence. Memantine dosage: 20 MG QD PO. During the same period patient was treated with AMLODIPINE BESYLATE, TEPRENONE, ASPIRIN, URSODIOL, TERBINAFINE, BETAMETHASONE DIPROPIONATE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5759053-0
Memantine side effect was reported by a Consumer or non-health professional from FRANCE on May 16, 2008. Female patient, 86 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: electroencephalogram abnormal, epilepsy , gait disturbance, somnolence, tremor. Memantine dosage: 20 MG QD PO. During the same period patient was treated with ATHYMIL, RISPERDAL, IMOVANE, KARDEGIC. Patient recovered.

Memantine Side Effects Report #5762092-7
Memantine side effect was reported by a Health Professional from GERMANY on May 16, 2008. Female patient, 86 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: electroencephalogram abnormal, epilepsy , gait disturbance, somnolence, tremor. Memantine dosage: 20 MG QD PO. During the same period patient was treated with ATHYMIL, RISPERDAL, IMOVANE, KARDEGIC. Patient recovered.

Memantine Side Effects Report #5172435-3
Memantine side effect was reported by a Health Professional from FRANCE on Nov 14, 2006. Male patient, 84 years of age, weighting 136.7 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: bedridden, dysstasia, gait disturbance, somnolence. Memantine dosage: 5 MG QD PO. During the same period patient was treated with DILTIAZEM HYDROCHLORIDE, ASPIRIN, CITALOPRAM HYDROBROMIDE, ATARAX. Patient recovered.


Memantine Side Effects Report #4848554-5
Memantine side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 28, 2005. Male patient, 83 years of age, weighting 153.9 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: abnormal behaviour, anger, anxiety , disorientation, irritability, nightmare, somnolence, speech disorder. Memantine dosage: 10 MG QD PO. During the same period patient was treated with ARICEPT, LISINOPRIL. Patient recovered.

Memantine Side Effects Report #4709965-1
Memantine side effect was reported by a Health Professional from SPAIN on June 20, 2005. Female patient, 79 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: asthenia, fatigue, incontinence, somnolence. Memantine dosage: 20 MG QD PO. During the same period patient was treated with ARICEPT. Patient recovered.

Memantine Side Effects Report #4710752-9
Memantine side effect was reported by a Health Professional from SPAIN on June 30, 2005. Female patient, 79 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: asthenia, faecal incontinence, fatigue, somnolence, urinary incontinence . Memantine dosage: 20 MG QD PO. During the same period patient was treated with ARICEPT. Patient recovered.

Memantine Side Effects Report #5121887-3
Memantine side effect was reported by a Health Professional from FRANCE on Sept 18, 2006. Male patient, 73 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: atrial flutter, blood sodium increased, c-reactive protein increased, consciousness fluctuating, fall , overdose, somnolence. Memantine dosage: 10 MG BID PO. During the same period patient was treated with HEPARIN CALCIUM, ARICEPT, SECTRAL, PERINDOPRIL ERBUMINE, LASIX, IKOREL, KARVEA HCT, ASPIRIN. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5874781-4
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Aug 19, 2008. Male patient, 65 years of age, weighting 125.7 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, coma, convulsion, dyskinesia, excoriation, hypophagia, infection , somnolence. Memantine dosage: 20 MG (20 MG, 1 IN 1 D), ORAL; 20 MG (20 MG, 1 IN 1 D), ORAL. During the same period patient was treated with BROTIZOLAM, AMLODIPINE BESYLATE, RISPERIDONE. Patient was hospitalized. Patient recovered.


Memantine Side Effects Report #4945304-9
Memantine side effect was reported by a Pharmacist from UNITED STATES on Mar 15, 2006. Male patient, 81 years of age, weighting 200.6 lb, was diagnosed with dementia  and was treated with Memantine. After drug was administered, patient experienced the following side effects: somnolence. Memantine dosage: 10 MG BID PO. During the same period patient was treated with RIVASTIGMINE, QUETIAPINE, VENLAFAXINE, SIMVASTATIN. Patient recovered.

Memantine Side Effects Report #6068405-3
Memantine side effect was reported by a Health Professional from UNITED KINGDOM on Jan 21, 2009. Male patient, 75 years of age, weighting 182.5 lb, was diagnosed with dementia  and was treated with Memantine. After drug was administered, patient experienced the following side effects: dyskinesia, dyspnoea, miosis, musculoskeletal stiffness, restlessness, sedation, somnolence, unresponsive to stimuli. Memantine dosage: 5 MG (5 MG, 1 IN 1 D), ORAL. During the same period patient was treated with AMLODIPINE, ASPIRIN, DOXAZOSIN MESYLATE, FUROSEMIDE, OMEPRAZOLE, PAROXETINE, TELMISARTAN, TOLBUTAMIDE. Patient died on 05/02/2008.

Memantine Side Effects Report #6140009-3
Memantine side effect was reported by a Health Professional from GERMANY on Mar 18, 2009. Male patient, weighting 154.3 lb, was diagnosed with dementia  and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood glucose increased, blood sodium decreased, febrile infection, inflammation, somnolence, syncope. Memantine dosage: 20 MG (20 MG, 1 IN 1 D),ORAL. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5955504-7
Memantine side effect was reported by a Health Professional from GERMANY on Oct 30, 2008. Female patient, 90 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: aggression, agitation, circadian rhythm sleep disorder, delirium, somnolence. Memantine dosage: 20 MG (10 MG, 2 IN 1 D), ORAL. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #4896764-3
Memantine side effect was reported by a Health Professional from FRANCE on Jan 09, 2006. Female patient, 90 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: blood creatine increased, disturbance in attention, fall , somnolence. Memantine dosage: 10 MG QD PO. During the same period patient was treated with RISPERDAL, ARICEPT, CITALOPRAM HYDROBROMIDE, LIPANTHYL, ALDACTONE. Patient was hospitalized. Patient recovered.


Memantine Side Effects Report #5954666-5
Memantine side effect was reported by a Pharmacist from GERMANY on Nov 04, 2008. Male patient, 84 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: anorexia, depressed mood, hypotonia, somnolence. Memantine dosage: 5 MG (5 MG, 1 IN 1 D), ORAL. During the same period patient was treated with RAMINYL. Patient recovered.

Memantine Side Effects Report #5468661-6
Memantine side effect was reported by a Health Professional from FRANCE on Sept 06, 2007. Male patient, 79 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: blood glucose increased, blood sodium increased, dehydration, lung infection, renal failure acute, somnolence. Memantine dosage: 10 MG QD PO. During the same period patient was treated with VALSARTAN AND HYDROCHLOROTHIAZIDE, ARICEPT, DEROXAT, RISPERDAL. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5843106-2
Memantine side effect was reported by a Health Professional from GERMANY on July 29, 2008. Male patient, 75 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: brain scan abnormal, cerebral atrophy, cerebral ischaemia, electroencephalogram abnormal, grand mal convulsion, somnolence. Memantine dosage: 20 MG 910 MG, 2 IN 1 D), ORAL. During the same period patient was treated with ARICEPT, KARDEGIC, OMIX, FONZYLANE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5878511-1
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Aug 26, 2008. Male patient, child 3 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: dizziness , gait disturbance, somnolence. Memantine dosage: unknown. Patient was hospitalized. Patient recovered.